Search results for: England
Filter search results
Two New Papers on EQ-5D-5L Valuation in Ireland
21 August 2018
…for the EQ-5D-5L. PharmacoEconomics. DOI Related research Devlin, N., Shah, K., Feng, Y., Mulhern, B. and van Hout, B., 2018. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Economics,…
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
…for the English National Health Service (NHS) for the same period at 8.0%. However, NHS Digital reported much-reduced medicines expenditure growth for England of 3.5% for 2016/17, suggesting a complex…
Private Provision of Publicly Funded Health Care: The Economics of Ownership
10 September 2018
…Office of Health Economics. RePEc Sussex, J. (2009). How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to the NHS Patients in England. OHE Briefing, London:…
OHE at the EuroQol Plenary Meeting 2018
2 October 2018
…quality of primary care in England affects patients’ self-reported outcomes. The analysis used data from the GP Patient Survey and the national Quality and Outcomes Framework (QOF) datasets to estimate…
Securing Funds for the Proposed NHS Multi-year Funding: The Feasibility of Using a Hypothecated Tax
24 October 2018
…UK Government announced an increase of 3.4% per annum in spending on the NHS in England for each of three years. It indicated that taxes will rise to pay for…
OHE’s Annual Report to the Charity Commission 2017
16 November 2018
…for England and Wales, its first since becoming a registered charity in December 2016. OHE’s charitable status represents an important watershed in OHE’s evolution as a health economics research organisation….
OHE Achievements in 2018
27 December 2018
…NHS England. The EuroQol Foundation has funded our research on clinical quality of primary care and patient self-reported outcomes. And there’s more in the pipeline to be announced in 2019….
OHE Lunchtime Seminar: What Can NHS Trusts do to Reduce Cancer Waiting Times?
10 January 2019
…of patients diagnosed with cancer should receive treatment within 62 days of referral. However, waiting times are increasing in England: the 62-day target has not been met since late 2013…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…considered, especially in the world of medical devices and equipment oftentimes excluded from price benchmarking and evidence conversations. Not dissimilar to the ECRI model, NHS England set up a database…